Aims
Corticosteroids are widely used in patients with cardiac sarcoidosis
(CS). In addition, upgrading to
cardiac resynchronization therapy
(CRT) is sometimes needed. This study aimed to investigate the impact of
corticosteroid use on the clinical outcomes following CRT upgrades.